Tao Wang

MIR‐138‐5P inhibits the progression of prostate cancer by targeting FOXC1

Ying Xiong, Hui Huang, Zhangyan Zhou, 2020, Molecular genetics & genomic medicine.

Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy.

Cuidan Li, S. Cang, Ziguang Xu, 2022, Clinical lung cancer.